Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Do cyclo-oxygenase 2 inhibitors increase the risk of cardiovascular events?

Do cyclo-oxygenase 2 inhibitors increase the risk of cardiovascular events? Nat Clin Pract Oncol. 2005 Sep; 2(9):434-5.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.